Arkolith/Insider Trading/TALS/Form 4

Requadt Scott

Chief Executive Officer, DirectorTalaris Therapeutics, Inc. (TALS) · full profile →Form 4 · filed Aug 2, 2022
Net Buying
Open-Market Buys
$167K
Open-Market Sells
$0
Net Open-Market Flow
$167K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 29, 2022Buy(P)39K$4.25$167K509K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-027404) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML